
Addressing antimicrobial resistance (AMR) for better cancer care – the importance of effective antimicrobial stewardship
Register
People with cancer are more susceptible to infections due to the lowering of their immune defences. As many as one in five cancer patients undergoing treatment is hospitalized due to an infection and infections are the second leading cause of death for people living with cancer. The emergence of drug-resistant pathogens is a grave threat to cancer care. There is an urgent need to address the critical issue of AMR as it will roll back progress made to date in modern medicines, including cancer treatment. The time to act is now.
In this regard, the second UN high-level meeting on AMR took place on 26 September 2024, where the political declaration on addressing AMR was adopted by Members States. At this meeting, Member States committed to a set of actions to mitigate AMR across all sectors, using a One Health approach that recognises the interconnectedness between human, animal, agriculture and environmental health. There are several commitments outlined under action on human health to effectively address AMR including focus on knowledge and awareness raising, ensuring access to appropriate therapies, effective stewardship and infection prevention and control (IPC) etc. Progress in these areas will have a positive impact on cancer care outcomes.
All key stakeholders must come together to accelerate progress and implement actions to address AMR at national, regional and global levels. AMR is a complex and widespread issue that requires immediate and collaborative action.
In this regard, the London Global Cancer Week is an annual event that brings together all the relevant stakeholders and experts in the field. It is an ideal platform to bring together experts from the cancer and AMR fields to discuss what action needs to be taken to address this challenge.
Objective and expected results
The objective of this virtual dialogue is to emphasize the crucial role of effective antimicrobial stewardship (AMS) in promoting the responsible use of medications to manage infections, ultimately contributing to improved outcomes in cancer care.
